Clinical Trial Update: Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients [Phase 3]

View source ↗

Summary

Clinical trial update for the Phase 3 ENRICHD study assessing recovery in coronary heart disease; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Major Depressive Disorder
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED